4/2/2014 9:10:35 AM
WALTHAM, Mass., April 2, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced that two posters highlighting its niraparib and immuno-oncology programs will be presented at the American Association of Cancer Research (AACR) meeting, which will take place April 5-9, 2014 in San Diego, California.
Help employers find you! Check out all the jobs and post your resume.
comments powered by